SYNLOGIC, INC.

SYBXSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1527599

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues	$8.0K	$3.4M	$1.2M	$1.8M	$545.0K
Research and Development Expense	$9.2M	$44.0M	$52.0M	$47.1M	$47.5M
Operating Expenses	$41.0M	$58.5M	$68.6M	$62.5M	$61.0M
Operating Income (Loss)	-$41.0M	-$55.2M	-$67.4M	-$60.8M	-$60.5M
Interest Expense	—	—	$2.0K	$2.0K	$6.0K
Nonoperating Income (Expense)	$17.6M	-$6.1M	$1.3M	$204.0K	$1.3M
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$23.4M	-$61.3M	-$66.1M	—

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$19.8M	$75.5M	$110.9M	$174.7M	$143.8M
Assets, Current	$19.8M	$49.9M	$79.8M	$133.3M	$106.8M
Cash and Cash Equivalents, at Carrying Value	$18.9M	$24.0M	$15.9M	$16.4M	$32.5M
Liabilities	—	—	—	—	—
Liabilities, Current	$7.1M	$30.3M	$12.1M	$10.1M	$8.3M
Accounts Payable, Current	$164.0K	$1.5M	$1.8M	$1.9M	$2.0M
Stockholders' Equity Attributable to Parent	$32.8M	$82.6M	$147.3M	$115.1M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$31.7M	-$51.6M	-$56.9M	-$52.2M	-$39.6M
Net Cash Provided by (Used in) Investing Activities	$25.3M	$38.8M	$58.4M	-$53.3M	$32.5M
Net Cash Provided by (Used in) Financing Activities	$172.0K	$20.9M	-$2.0M	$89.4M	$13.4M
Payments to Acquire Property, Plant, and Equipment	$14.0K	$214.0K	$728.0K	$679.0K	$395.0K
Payments for Repurchase of Equity	—	—	$2.5M	$0.00	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)